These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33023317

  • 1. Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies.
    Sens J, Hoffmann D, Lange L, Vollmer Barbosa P, Morgan M, Falk CS, Schambach A.
    Hum Gene Ther; 2021 Jan; 32(1-2):77-95. PubMed ID: 33023317
    [Abstract] [Full Text] [Related]

  • 2. Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages.
    Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M, Falk CS, Klein C, Lachmann N, Schambach A.
    J Pers Med; 2021 Mar 20; 11(3):. PubMed ID: 33804706
    [Abstract] [Full Text] [Related]

  • 3. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.
    Mukhopadhyay S, Heinz E, Porreca I, Alasoo K, Yeung A, Yang HT, Schwerd T, Forbester JL, Hale C, Agu CA, Choi YH, Rodrigues J, Capitani M, Jostins-Dean L, Thomas DC, Travis S, Gaffney D, Skarnes WC, Thomson N, Uhlig HH, Dougan G, Powrie F.
    J Exp Med; 2020 Feb 03; 217(2):. PubMed ID: 31819956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.
    Xiao Y, Wang XQ, Yu Y, Guo Y, Xu X, Gong L, Zhou T, Li XQ, Xu CD.
    World J Gastroenterol; 2016 Jun 28; 22(24):5578-88. PubMed ID: 27350736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM, Keith-Magee AL, Yerkovich ST, Murcha M, Hart PH.
    Immunology; 2006 Sep 28; 119(1):8-17. PubMed ID: 16925527
    [Abstract] [Full Text] [Related]

  • 9. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis.
    Moran CJ, Walters TD, Guo CH, Kugathasan S, Klein C, Turner D, Wolters VM, Bandsma RH, Mouzaki M, Zachos M, Langer JC, Cutz E, Benseler SM, Roifman CM, Silverberg MS, Griffiths AM, Snapper SB, Muise AM.
    Inflamm Bowel Dis; 2013 Jan 28; 19(1):115-23. PubMed ID: 22550014
    [Abstract] [Full Text] [Related]

  • 10. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
    Wilbers RHP, van Raaij DR, Westerhof LB, Bakker J, Smant G, Schots A.
    PLoS One; 2017 Jan 28; 12(10):e0186317. PubMed ID: 29016674
    [Abstract] [Full Text] [Related]

  • 11. Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages.
    Pike KA, Hutchins AP, Vinette V, Théberge JF, Sabbagh L, Tremblay ML, Miranda-Saavedra D.
    Sci Signal; 2014 May 06; 7(324):ra43. PubMed ID: 24803538
    [Abstract] [Full Text] [Related]

  • 12. Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease.
    Lv JJ, Su W, Chen XY, Yu Y, Xu X, Xu CD, Deng X, Huang JB, Wang XQ, Xiao Y.
    World J Gastroenterol; 2021 Nov 28; 27(44):7705-7715. PubMed ID: 34908808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.
    Wu J, Niu P, Zhao Y, Cheng Y, Chen W, Lin L, Lu J, Cheng X, Xu Z.
    PLoS One; 2019 Nov 28; 14(2):e0212063. PubMed ID: 30807577
    [Abstract] [Full Text] [Related]

  • 15. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.
    Lin Z, Wang Z, Hegarty JP, Lin TR, Wang Y, Deiling S, Wu R, Thomas NJ, Floros J.
    World J Gastroenterol; 2017 Jul 21; 23(27):4897-4909. PubMed ID: 28785144
    [Abstract] [Full Text] [Related]

  • 16. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
    O'Farrell AM, Liu Y, Moore KW, Mui AL.
    EMBO J; 1998 Feb 16; 17(4):1006-18. PubMed ID: 9463379
    [Abstract] [Full Text] [Related]

  • 17. IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease.
    Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X.
    Gastroenterology Res; 2017 Apr 16; 10(2):65-69. PubMed ID: 28496525
    [Abstract] [Full Text] [Related]

  • 18. Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease.
    Lee CH, Hsu P, Nanan B, Nanan R, Wong M, Gaskin KJ, Leong RW, Murchie R, Muise AM, Stormon MO.
    J Crohns Colitis; 2014 Nov 16; 8(11):1551-6. PubMed ID: 24813381
    [Abstract] [Full Text] [Related]

  • 19. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L, Bradley L, Smith A, Foxwell B.
    J Immunol; 2004 Jan 01; 172(1):567-76. PubMed ID: 14688368
    [Abstract] [Full Text] [Related]

  • 20. Impaired IL-10 Receptor-mediated Suppression in Monocyte From Patients With Crohn Disease.
    Nunberg MY, Werner L, Kopylov U, Haberman Y, Lahad A, Weiss B, Shouval DS.
    J Pediatr Gastroenterol Nutr; 2018 May 01; 66(5):779-784. PubMed ID: 29045353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.